Plasma α-Melanocyte stimulating hormone predicts outcome in ischemic stroke

Stroke

Volumn 42, Issue 12, 2011, Pages 3415-3420

  Zierath, Dannielle ^a   Tanzi, Pat ^a   Cain, Kevin ^a   Shibata, Dean ^a   Becker, Kyra ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

MSH; Outcome; Stroke

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; HYDROCORTISONE; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALPHA-MSH; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE;

EID: 84856210255     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.627331     Document Type: Article

References (41)

1. D'Agostino G, Diano S. α-Melanocyte stimulating hormone: production and degradation. J Mol Med. 88:1195-1201.
2. Bicknell AB. The tissue-specific processing of pro-opiomelanocortin. J Neuroendocrinol. 2008;20:692-699. (Pubitemid 351858719)
3. Christensen H, Boysen G, Johannesen HH. Serum-cortisol reflects severity and mortality in acute stroke. J Neurol Sci. 2004;217:175-180. (Pubitemid 38056552)
4. Slowik A, Turaj W, Pankiewicz J, Dziedzic T, Szermer P, Szczudlik A. Hypercortisolemia in acute stroke is related to the inflammatory response. J Neurol Sci. 2002;196:27-32. (Pubitemid 34311536)
5. Neidert S, Katan M, Schuetz P, Fluri F, Ernst A, Bingisser R, et al. Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J Intern Med. 2011;269:420-432.
6. Magnoni S, Stocchetti N, Colombo G, Carlin A, Colombo A, Lipton JM, et al. α-Melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury. J Neurotrauma. 2003;20:251-260. (Pubitemid 36373822)
7. Savos AV, Gee JM, Zierath D, Becker KJ. α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke. J Cereb Blood Flow Metab. 2011;31:606-613.
8. Path G, Scherbaum WA, Bornstein SR. The role of interleukin-6 in the human adrenal gland. Eur J Clin Invest. 2000;30(suppl 3):91-95. (Pubitemid 32154558)
9. Becker K, Kalil A, Tanzi P, Zierath D, Savos A, Gee JM, et al. Autoimmune responses to brain following stroke are associated with worse outcome. Stroke. 2011;42:2763-2769.
10. Tanzi P, Cain K, Kalil A, Zierath D, Savos A, Gee JM, et al. Post-stroke infection: a role for il-1ra? Neurocrit Care. 2011;14:244-252.
11. Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, Lev MH, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2009;72:2104-2110.
12. Shishioh-Ikejima N, Ogawa T, Yamaguti K, Watanabe Y, Kuratsune H, Kiyama H. The increase of α-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients. BMC Neurol. 2010;10:73.
13. Mulley GP, Wilcox RG, Harrison MJ. Plasma cortisol as a measure of stress response in acute stroke. Stroke. 1989;20:1593.
14. Anne M, Juha K, Timo M, Mikko T, Olli V, Kyosti S, et al. Neurohormonal activation in ischemic stroke: effects of acute phase disturbances on long-term mortality. Curr Neurovasc Res. 2007;4:170-175. (Pubitemid 47235968)
15. Fassbender K, Schmidt R, Mossner R, Daffertshofer M, Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke: relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke. 1994;25:1105-1108. (Pubitemid 24164746)
16. Johansson A, Olsson T, Carlberg B, Karlsson K, Fagerlund M. Hypercortisolism after stroke-partly cytokine-mediated? J Neurol Sci. 1997;147:43-47.
17. Szczudlik A, Dziedzic T, Bartus S, Slowik A, Kieltyka A. Serum interleukin-6 predicts cortisol release in acute stroke patients. J Endocrinol Invest. 2004;27:37-41. (Pubitemid 38324717)
18. Orion D, Schwammenthal Y, Reshef T, Schwartz R, Tsabari R, Merzeliak O, et al. Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischaemia. Eur J Neurol. 2008;15:323-328. (Pubitemid 351422377)
19. Forslin Aronsson S, Spulber S, Popescu LM, Winblad B, Post C, Oprica M, et al. α-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides. 2006;40:65-75. (Pubitemid 43255414)
20. Giuliani D, Ottani A, Mioni C, Bazzani C, Galantucci M, Minutoli L, et al. Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. Eur J Pharmacol. 2007;570:57-65. (Pubitemid 47248665)
21. Chen G, Frokiaer J, Pedersen M, Nielsen S, Si Z, Pang Q, et al. Reduction of ischemic stroke in rat brain by αmelanocyte stimulating hormone. Neuropeptides. 2008;42:331-338.
22. Huh SK, Lipton JM, Batjer HH. The protective effects of α-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery. 1997;40:132-139; discussion 139-140.
23. Huang QH, Hruby VJ, Tatro JB. Systemic α-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release. Am J Physiol. 1998;275:R524-R530.
24. Namba K, Kitaichi N, Nishida T, Taylor AW. Induction of regulatory T cells by the immunomodulating cytokines α-melanocyte-stimulating hormone and transforming growth factor-β2. J Leukoc Biol. 2002;72:946-952. (Pubitemid 35365168)
25. Ng TF, Kitaichi N, Taylor AW. In vitro generated autoimmune regulatory T cells enhance intravitreous allogeneic retinal graft survival. Invest Ophthalmol Vis Sci. 2007;48:5112-5117. (Pubitemid 351260921)
26. Taylor A, Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide α-melanocyte stimulating hormone (α-MSH). Immunol Cell Biol. 2001;79:358-367. (Pubitemid 32744282)
27. Taylor AW, Streilein JW, Cousins SW. α-Melanocyte-stimulating hormone suppresses antigen-stimulated t cell production of γ-interferon. Neuroimmunomodulation. 1994;1:188-194.
28. Han D, Tian Y, Zhang M, Zhou Z, Lu J. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinantade no associated virus-mediated α-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells. Gene Ther. 2007;14:383-395.
29. Taylor AW, Kitaichi N. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide α-melanocyte stimulating hormone (α-MSH) therapy. Brain Behav Immun. 2008;22:639-646. (Pubitemid 351794233)
30. Gee JM, Kalil A, Thullbery M, Becker KJ. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke. 2008;39:1575-1582.
31. Becker KJ, Kindrick DL, Lester MP, Shea C, Ye ZC. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab. 2005;25:1634-1644. (Pubitemid 41683174)
32. Demeneix B, Grant NJ. α-Melanocyte stimulating hormone promotes neurite outgrowth in chromaffin cells. FEBS Lett. 1988;226:337-342. (Pubitemid 18023245)
33. van der Neut R, Hol EM, Gispen WH, Bar PR. Stimulation by melanocortins of neurite outgrowth from spinal and sensory neurons in vitro. Peptides. 1992;13:1109-1115. (Pubitemid 23010903)
34. Antonawich FJ, Azmitia EC, Strand FL. Rapid neurotrophic actions of an ACTH/MSH (4-9) analogue after nigrostriatal 6-OHDA lesioning. Peptides. 1993;14:1317-1324.
35. Strand FL, Saint-Come C, Lee TS, Lee SJ, Kume J, Zuccarelli LA. ACTH/MSH (4-10) analog bim 22015 aids regeneration via neurotrophic and myotrophic attributes. Peptides. 1993;14:287-296.
36. Adan RA, van der Kraan M, Doornbos RP, Bar PR, Burbach JP, Gispen WH. Melanocortin receptors mediate α-MSH-induced stimulation of neurite outgrowth in neuro 2a cells. Brain Res Mol Brain Res. 1996;36:37-44. (Pubitemid 26060732)
37. Giuliani D, Ottani A, Minutoli L, Stefano VD, Galantucci M, Bitto A, et al. Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene zif268. Brain Behav Immun. 2009;23:844-850.
38. Giuliani D, Mioni C, Altavilla D, Leone S, Bazzani C, Minutoli L, et al. Both early and delayed treatment with melanocortin 4 receptorstimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology. 2006;147:1126-1135. (Pubitemid 43244343)
39. Giuliani D, Leone S, Mioni C, Bazzani C, Zaffe D, Botticelli AR, et al. Broad therapeutic treatment window of [nle (4), d-phe (7)]α- melanocytestimulating hormone for long-lasting protection against ischemic stroke, in mongolian gerbils. Eur J Pharmacol. 2006;538:48-56. (Pubitemid 44255728)
40. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci. 2002;5:514-516. (Pubitemid 34568991)
41. Schulte-Herbruggen O, Quarcoo D, Brzoska T, Klehmet J, Meisel A, Meisel C. α-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1. Exp Neurol. 2008;210:731-739.